First Trust Japan AlphaDEX FundFJP

The First Trust Japan AlphaDEX Fund (FJP) is a Japan-focused ETF that uses a proprietary rules-based selection process to pick stocks from the S&P Japan BMI universe, favouring liquidity and momentum metrics over traditional valuation screens. The fund’s mandate is explicit: it’s not trying to beat the Nikkei by picking “undervalued” stocks, but to relative strength a broad Japanese equity benchmark by tilting toward stocks exhibiting strong price momentum and trading volume. The difference between the marketing and the mechanism is the difference between a chef and a vending machine: one prepares a meal, the other dispenses a snack at a price.

The fund’s holdings are a rotating cast of mid-to-large Japanese companies, with the top ten positions-including firms like Nidec, Advantest, and Tokyo Electron-accounting for roughly a quarter of the portfolio. Concentration risk is baked in, but the issuer markets this as “smart beta” rather than a closet indexing play. The expense ratio of 0.80% sits in the upper tier for Japan-focused ETFs, reflecting the cost of the selection process and the fund’s active rebalancing cadence. Liquidity is adequate, with average daily volume ticking over 30,000 shares, but the fund is not a blockbuster by any stretch, leaving investors to wonder who exactly is paying for the privilege of this particular stock sieve.

The fund’s existence is documented in SEC filings, where its structure as a unit investment trust is laid bare: it’s a rules-driven, transparent basket with a quarterly rebalance that spits out fresh holdings like clockwork. The issuer’s prospectus makes no bones about the methodology-stocks are screened for liquidity and momentum, then weighted by their scores-so there’s no mystery about what you’re getting. The fund’s AUM of $423 million, while respectable, is dwarfed by passive Japan ETFs, underscoring that the real market here is the issuer’s fee extraction rather than the investable universe.

For a fund that pitches “alpha from Japan,” the Nasdaq ticker page offers only the barest of clues: daily price, volume, and a link to the fund’s fact sheet. There’s no embedded chart, no analyst commentary, and no hint of the human drama behind the selection process. The fund’s price action is a lagging indicator of its holdings’ performance, but the real story is the fee, the rules, and the revolving door of stocks that pass the screen. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/fjp)

What’s missing from the record is any granular breakdown of the fund’s top holdings’ fundamentals-revenue, profit margins, or cash flow-so investors are left to trust the algorithm rather than the numbers. The fund’s fact sheet, accessible via the SEC’s EDGAR portal, confirms the holdings and weights but offers no insight into why these stocks were chosen over others in the same universe. The fund’s prospectus, meanwhile, is a dry document that spells out the rules but says nothing about the outcomes. Until the fund publishes a performance attribution analysis that links its returns to the momentum factor, the “alpha” claim remains an article of faith rather than a proven thesis.